Beta Bionics, Inc. (NASDAQ:BBNX) Q1 2026 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Beta Bionics First Quarter 2026 Earnings Conference Call.
Beta Bionics Inc. (BBNX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 4,354,501 | $43,632,100 | +72% | 1.77% |
| 2. | Farallon Capital Thomas Steyer | 3,607,920 | $36,151,358 | -17% | 0.21% |
| 3. | Point72 Asset Management Steve Cohen | 2,525,040 | $25,300,901 | +156% | 0.03% |
| 4. | Vestal Point Capital Ryan Wilder | 2,211,518 | $22,159,410 | +269% | 0.62% |
| 5. | Eversept Partners Kamran Moghtaderi | 1,414,838 | $14,176,677 | +109% | 0.75% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 33,350 | $566,950.00 | 59,019 | 2025-01-31 | Filing | |
| $17.00 | 1,000,000 | $17,000,000.00 | 3,901,599 | 2025-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.61 | 4,378 | $55,193.88 | 184,415 | 2026-06-02 | Filing | |
| $12.61 | 5,329 | $67,183.24 | 130,887 | 2026-06-02 | Filing | |
| $12.61 | 4,222 | $53,227.18 | 173,849 | 2026-06-02 | Filing | |
| $12.61 | 6,676 | $84,165.00 | 166,053 | 2026-06-02 | Filing | |
| $12.61 | 16,872 | $212,706.99 | 420,937 | 2026-06-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,945,488 | $59,567,287 | 0.99% | |
| 2. | 4,227,634 | $42,360,893 | 0% | |
| 3. | 3,708,043 | $37,154,591 | 8.82% | |
| 4. | 3,038,595 | $30,446,722 | 0% | |
| 5. | 2,000,000 | $20,040,000 | 0.2% |
News See All
Beta Bionics, Inc. (NASDAQ:BBNX) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Beta Bionics Inc. Q4 and Full Year 2025 Earnings Conference Call and Webcast.
Beta Bionics, Inc. (NASDAQ:BBNX) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Beta Bionics Third Quarter 2025 Earnings Conference Call.
Goldman Sachs Upgrades Beta Bionics (BBNX) to Buy, Raises PT to $26 on Strong Growth and Market Outlook
Beta Bionics Inc. (NASDAQ:BBNX) is one of the best hot stocks to invest in.
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
Beta Bionics, Inc. (NASDAQ:BBNX) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Beta Bionics Second Quarter 2025 Earnings Conference Call.
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.
Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating
As per the analyst, the insulin pumps are a double-digit growth category, with the company taking share from the low base. The firm believes that Beta Bionics, Inc.
Beta Bionics, Inc. (NASDAQ:BBNX) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Beta Bionics First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center